474 related articles for article (PubMed ID: 19549575)
1. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of fungal infections in children and adolescents with cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
[TBL] [Abstract][Full Text] [Related]
3. Fungal infections in neutropenic cancer patients.
Parvez T
J Coll Physicians Surg Pak; 2003 Nov; 13(11):669-73. PubMed ID: 14700501
[TBL] [Abstract][Full Text] [Related]
4. Management of immunocompromised patients with evidence of an invasive mycosis.
Walsh TJ
Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563
[TBL] [Abstract][Full Text] [Related]
5. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
[TBL] [Abstract][Full Text] [Related]
6. Invasive fungal infections in hematology: new trends.
Martino R; Subirà M
Ann Hematol; 2002 May; 81(5):233-43. PubMed ID: 12029531
[TBL] [Abstract][Full Text] [Related]
7. [Mycoses and their treatment in malignant hemopathies].
Martino P; Girmenia C
Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
[TBL] [Abstract][Full Text] [Related]
8. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
Ruhnke M; Maschmeyer G
Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
[TBL] [Abstract][Full Text] [Related]
9. Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Chanock SJ; Walsh TJ
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S15-20. PubMed ID: 8971401
[TBL] [Abstract][Full Text] [Related]
10. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
Singh N
Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
[TBL] [Abstract][Full Text] [Related]
11. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
Jantunen E; Anttila VJ; Ruutu T
Bone Marrow Transplant; 2002 Dec; 30(12):925-9. PubMed ID: 12476286
[TBL] [Abstract][Full Text] [Related]
12. [Fungal infections in transplantation patients].
Colomba C; Antinori S
Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
[TBL] [Abstract][Full Text] [Related]
13. Colletotrichum species as emerging opportunistic fungal pathogens: a report of 3 cases of phaeohyphomycosis and review.
O'Quinn RP; Hoffmann JL; Boyd AS
J Am Acad Dermatol; 2001 Jul; 45(1):56-61. PubMed ID: 11423835
[TBL] [Abstract][Full Text] [Related]
14. Prevention of fungal infections in the immunocompromised host.
Mahfouz T; Anaissie E
Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Cornely OA; Böhme A; Buchheidt D; Glasmacher A; Kahl C; Karthaus M; Kern W; Krüger W; Maschmeyer G; Ritter J; Salwender HJ; Sandherr M; Schiel X; Schüttrumpf S; Sieniawski M; Silling G; Ullmann AJ; Wolf HH;
Ann Hematol; 2003 Oct; 82 Suppl 2():S186-200. PubMed ID: 13680164
[TBL] [Abstract][Full Text] [Related]
16. Stem cell transplantation post invasive fungal infection is a feasible task.
Avivi I; Oren I; Haddad N; Rowe JM; Dann EJ
Am J Hematol; 2004 Jan; 75(1):6-11. PubMed ID: 14695626
[TBL] [Abstract][Full Text] [Related]
17. Systemic fungal infections: major problems in cancer patients.
Powles RL; Mehta J
Indian J Cancer; 1994 Sep; 31(3):180-4. PubMed ID: 8557296
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of fungal infections in bone marrow transplantation.
Mossad SB
Curr Hematol Rep; 2003 Jul; 2(4):302-9. PubMed ID: 12901327
[TBL] [Abstract][Full Text] [Related]
19. Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts.
Erer B; Galimberti M; Lucarelli G; Giardini C; Polchi P; Baronciani D; Gaziev D; Angelucci E; Izzi G
Bone Marrow Transplant; 2000 Apr; 25(7):745-9. PubMed ID: 10745260
[TBL] [Abstract][Full Text] [Related]
20. Treatment of fungal and other opportunistic infections in immunocompromised patients.
Wade JC
Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
